Form D · Pharmaceuticals
PharmaCielo Holdings Ltd.
Toronto, A6 · CIK 0001641777
Offering snapshot reported Feb 25, 2019 · SEC filing
- Reported sold
- $6.32M Offering amount: $6.32M
- Investors reported
- 107 Form D · investor count
- Minimum accepted
- $17.6K Reported outside-investor minimum
- First sale
- Jun 25, 2018 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$5,839,553 → $6,315,156
- Reported investors101 → 107
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 25, 2019 | Amendment | $6,315,156 | $475,603vs Jul 9, 2018 | 107 | SEC filing |
| Jul 9, 2018 | Initial | $5,839,553 | No comparison | 101 | SEC filing |
| Dec 20, 2017 | Initial | $1,957,837 | No comparison | 51 | SEC filing |
| Jul 10, 2017 | Initial | $2,960,000 | No comparison | 54 | SEC filing |
| May 5, 2017 | Initial | $3,712,000 | No comparison | 76 | SEC filing |
| Jun 30, 2016 | Initial | $116,500 | No comparison | 6 | SEC filing |
| May 31, 2016 | Initial | $4,023,102 | No comparison | 108 | SEC filing |
| Feb 18, 2016 | Amendment | $2,982,500 | -$340,000vs Feb 5, 2016 | 75 | SEC filing |
| Feb 5, 2016 | Initial | $3,322,500 | No comparison | 82 | SEC filing |
| May 13, 2015 | Initial | $686,250 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-316289
2,504,746 Subscription Receipts were sold at C$3.35 per Subscription Receipt (US$2.52 per Subscription Receipt, based on exchange rate of US$1:C$1.3303 on 6/25/2018; US$2.56 per Subscription Receipt, based on exchange rate of US$1:C$1.3088 on 7/25/2018).
2,504,746 Subscription Receipts at C$3.35 per Subscription Receipt, convertible into shares upon satisfaction of escrow release conditions at or before September 30, 2018.
Source: Form D, filed Feb 25, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Attard | Director, Executive |
| Douglas Bache | Director |
| Federico Cock Correa | Director |
| David Gordon | Executive |
| Christopher Hansen | Director |
| Christopher A. Hansen | Director |
| Brian Henderson | Director |
| Brian Henderwson | Director |
| Ltd. High Alert Investment Management | Promoter |
| N/A High Alert Investment Management Ltd. | Promoter |
| Delon Human | Director |
| John Knapp | Executive |
| Scott Laitinen | Executive |
| Simon Langelier | Director |
| Matteo Pellegrini | Director |
| Kenneth Phillippe | Executive |
| Juan Manuel Ruiz | Director, Executive |
| Patricio A. Stocker | Director, Executive |
| Patricio A. Stocker | Director, Executive |
| N/A Stocker International Inc. | Promoter |
| Carlos Manuel Uribe | Director |
| Carlos Uribe | Director |
| Henning Von Koss | Director |
| Anthony Wile | Director, Executive |
| David Yun | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
82 Richmond Street East, Suite 200
Toronto, A6, M5C 1P1
Toronto, A6, M5C 1P1